Lee Surkin, MD
Cardiovascular Disease · Greenville, NCNPI 1093822421
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $43,248 of the $49,634 with a category attached, or 87.1%. Jazz Pharmaceuticals Inc. accounts for 62.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $18,481 and has fallen 58.0% since, to $7,760 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $855.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$31K
- Takeda Pharmaceuticals U.S.A., Inc.$15K
- Alkermes, Inc.$3K
- Harmony Biosciences LLC$37
- Amgen$34
- Amarin Pharma, Inc.$29
- plus $67 from 3 others
Across 1 payment — averaging $4712.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$5K
What the payments were for
- Consulting fees$43,24887%
- Travel & lodging$4,93510%
- Food & beverage$1,4513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 45 | $30,754 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $15,463 |
| Alkermes, Inc. | 1 | $3,250 |
| Harmony Biosciences LLC | 1 | $37 |
| Amgen | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $29 |
| Novo Nordisk | 2 | $26 |
| Roche Diagnostics Corporation | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$49,634 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Greenville
- Rajasekhar NekkantiGreenville$97K
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
- Robert MentzDurham$489K
- Sean PokorneyMorganton$477K
- Adrian HernandezDurham$409K
- Sanjeev GulatiCharlotte$406K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.